tradingkey.logo

Alto Neuroscience Inc

ANRO
19.690USD
-0.350-1.75%
Close 12/23, 16:00ETQuotes delayed by 15 min
534.94MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Alto Neuroscience Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-91.40%-11.52M
---7.76M
---6.63M
---7.52M
---6.02M
Net income from continuing operations
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-35.52%-15.20M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
-46.59%-11.22M
---9.14M
---8.66M
---7.28M
---7.65M
Operating gains losses
34.43%164.00K
49.56%169.00K
76.29%171.00K
84.78%170.00K
46.99%122.00K
0.89%113.00K
12.79%97.00K
-5.15%92.00K
--83.00K
--112.00K
--86.00K
--97.00K
Other non-cash items
--195.00K
-75.67%192.00K
1109.72%871.00K
197.18%211.00K
-100.00%0.00
1043.48%789.00K
-4.00%72.00K
77.50%71.00K
--65.00K
--69.00K
--75.00K
--40.00K
Change in working capital
-53.45%1.30M
-9.44%1.29M
-1727.06%-4.66M
108.56%99.00K
234.05%2.79M
138.33%1.43M
73.87%-255.00K
-241.32%-1.16M
--834.00K
--600.00K
---976.00K
--818.00K
-Change in receivables
----
----
----
---8.00K
-100.00%0.00
-100.00%0.00
121.62%8.00K
-100.00%0.00
--295.00K
--67.00K
---37.00K
--1.02M
-Change in prepaid expenses
-15.59%628.00K
310.48%509.00K
5.42%-1.69M
266.40%458.00K
1007.32%744.00K
-67.96%124.00K
-285.56%-1.79M
144.17%125.00K
---82.00K
--387.00K
---464.00K
---283.00K
Cash from non-recurring investing activities
Cash from operating activities
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
-91.40%-11.52M
---7.76M
---6.63M
---7.52M
---6.02M
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
-100.00%0.00
-89.29%24.00K
43.75%506.00K
2237.21%1.00M
529.63%340.00K
966.67%224.00K
467.74%352.00K
--43.00K
--54.00K
--21.00K
--62.00K
Capital expenditures
-100.00%0.00
-100.00%0.00
-89.29%24.00K
43.75%506.00K
2237.21%1.00M
529.63%340.00K
966.67%224.00K
467.74%352.00K
--43.00K
--54.00K
--21.00K
--62.00K
Net cash flow from disposal of fixed assets
-100.00%0.00
-100.00%0.00
-89.29%24.00K
43.75%506.00K
2237.21%1.00M
529.63%340.00K
966.67%224.00K
467.74%352.00K
--43.00K
--54.00K
--21.00K
--62.00K
Net cash flow from other investing activities
--0.00
----
----
----
----
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
100.00%0.00
100.00%0.00
89.29%-24.00K
-43.75%-506.00K
-2237.21%-1.00M
-529.63%-340.00K
-966.67%-224.00K
-467.74%-352.00K
---43.00K
---54.00K
---21.00K
---62.00K
Financing cash flow
Cash flow from continuous financing activities
-88.38%153.00K
361.97%613.00K
-93.22%9.13M
-99.89%49.00K
2587.76%1.32M
-358.82%-234.00K
438.24%134.56M
118.81%43.13M
--49.00K
---51.00K
--25.00M
--19.71M
Net cash flow from debt Issuance/repayment
-100.00%0.00
--750.00K
--9.47M
--0.00
--1.25M
----
----
----
----
----
----
--9.82M
Net cash flow from common stock issuance/repurchase
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
--137.58M
625.00%29.00K
--152.00K
--0.00
--0.00
--4.00K
Net cash flow from preferred stock issuance/repurchase
----
----
----
-100.00%0.00
--0.00
--0.00
-100.00%0.00
348.21%45.00M
--0.00
--0.00
--25.00M
--10.04M
Proceeds from stock option exercised by employees
128.36%153.00K
-100.00%0.00
1880.00%198.00K
--49.00K
255.81%67.00K
41.86%61.00K
--10.00K
----
---43.00K
--43.00K
--0.00
----
Net cash flow from other financing activities
--0.00
53.56%-137.00K
81.98%-546.00K
100.00%0.00
100.00%0.00
-213.83%-295.00K
---3.03M
-1108.28%-1.90M
---60.00K
---94.00K
--0.00
---157.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-88.38%153.00K
361.97%613.00K
-93.22%9.13M
-99.89%49.00K
2587.76%1.32M
-358.82%-234.00K
438.24%134.56M
118.81%43.13M
--49.00K
---51.00K
--25.00M
--19.71M
Net cash flow
Beginning cash balance
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
255.25%182.20M
228.01%193.62M
213.01%205.90M
70.75%82.55M
47.83%51.29M
--59.03M
--65.78M
--48.34M
--34.70M
Current period cash flow changes
14.46%-9.77M
-7.30%-13.17M
-106.06%-7.47M
-143.10%-13.47M
-47.54%-11.42M
-81.80%-12.27M
607.43%123.35M
129.03%31.26M
---7.74M
---6.75M
--17.44M
--13.65M
Effect of exchange rate changes
42.86%-4.00K
40.00%-3.00K
-340.00%-22.00K
50.00%6.00K
-138.89%-7.00K
54.55%-5.00K
73.68%-5.00K
-80.00%4.00K
--18.00K
---11.00K
---19.00K
--20.00K
Ending cash balance
-24.09%138.32M
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
255.25%182.20M
228.01%193.62M
213.01%205.90M
70.75%82.55M
--51.29M
--59.03M
--65.78M
--48.34M
Free cash flow
22.10%-9.92M
-14.50%-13.78M
-47.94%-16.58M
-13.90%-13.53M
-63.05%-12.73M
-79.91%-12.03M
-48.54%-11.21M
-95.23%-11.88M
---7.81M
---6.69M
---7.54M
---6.08M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI